Amgen (AMGN)

Cash & Short-Term Investments

$13.99B

Quarterly · Period ending: · USD

AMGN logo

AMGN Cash & Short-Term Investments

Latest reported$13.99B
AMGN Quarterly Cash & Short-Term Investments ($66.60M → $13.99B)
High-resolution chart · PNG

AMGN cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Amgen Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
13,989,000,000
12,038,000,000
9,129,000,000
9,445,000,000
8,028,000,000
8,810,000,000
11,973,000,000
9,011,000,000
9,301,000,000
9,708,000,000
10,944,000,000
34,741,000,000
34,248,000,000
31,561,000,000
9,305,000,000
11,478,000,000
7,183,000,000
6,544,000,000
8,037,000,000
12,921,000,000
8,082,000,000
10,566,000,000
10,647,000,000
12,360,000,000
11,421,000,000
8,012,000,000
8,911,000,000
20,853,000,000
21,758,000,000
26,301,000,000
29,304,000,000
29,921,000,000
29,395,000,000
32,172,000,000
41,678,000,000
41,351,000,000
39,227,000,000
38,398,000,000
38,085,000,000
37,980,000,000
35,034,000,000
34,740,000,000
31,382,000,000
31,120,000,000
29,993,000,000
27,118,000,000
27,026,000,000
28,075,000,000
26,188,000,000
19,802,000,000
19,401,000,000
22,558,000,000
22,018,000,000
21,271,000,000
24,061,000,000
25,374,000,000
22,475,000,000
19,374,000,000
20,641,000,000
17,676,000,000
19,172,000,000
15,358,000,000
17,422,000,000
0
14,523,000,000
14,117,000,000
13,442,000,000
14,013,000,000
11,965,000,000
10,378,000,000
9,552,000,000
9,757,000,000
8,483,000,000
8,647,000,000
7,151,000,000
5,950,000,000
5,306,000,000
4,837,000,000
6,277,000,000
5,781,000,000
4,970,000,000
5,047,000,000
5,255,000,000
5,551,000,000
4,440,000,000
4,035,000,000
5,808,000,000
3,838,000,000
4,261,800,000
4,509,100,000
5,123,000,000
5,025,000,000
4,985,400,000
4,757,000,000
4,664,000,000
4,042,200,000
5,057,800,000
5,174,500,000
2,662,200,000
2,429,200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.